S
Shenzhen Huaxian Pharmaceutical Technology
A research and development company of pharmaceutical specialty raw materials and intermediates
About Shenzhen Huaxian Pharmaceutical Technology
Hwagen Pharm is a pioneering company in the pharmaceutical industry, specializing in the development of highly complex raw materials and intermediates. The company leverages core technologies such as organic catalyzing, bio enzyme catalyzing, and continuous streaming microchannels to create high-value products. These products are essential in the treatment of anti-cancer, anti-virus, and anti-respiratory diseases. Hwagen Pharm serves both domestic and international pharmaceutical enterprises, providing them with advanced materials that are crucial for the development of effective medications. The company operates in the biopharmaceutical market and generates revenue by selling these high-value raw materials and intermediates to pharmaceutical companies. Hwagen Pharm recently completed a billion-dollar financing round, underscoring its strong market position and growth potential.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 21.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Dec 2022 | $14M | $55M | Jiande High-speed Railway New Area Investment · Guangdong Technology Financial Group · Tuowei Group | ↗ |
| SERIES BOther financing | Aug 2021 | $23M | $93M | China Reform Fund Management · Renhe Capital | — |
Growth signals
Latest recorded traffic for Shenzhen Huaxian Pharmaceutical Technology is 960 monthly website visits, up 1820% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shenzhen Huaxian Pharmaceutical Technology in the Shenzhen ecosystem
The Shenzhen Huaxian Pharmaceutical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- WVWinning Ventures
Series A8 investors entered at this stage
- SIShenzhen Donghai Investment
- WCWinzac Capital
- RCRealharmony Capital
- CMChina Reform Fund Management
- RCRenhe Capital
- JIJiande High-speed Railway New Area Investment
Guangdong Technology Financial Group- TGTuowei Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shenzhen Huaxian Pharmaceutical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shenzhen Huaxian Pharmaceutical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








